HOTAIR and glioblastoma: When Tan and his group analyzed the levels of HOTAIR in serum samples obtained from GBM patients, they found that the levels of HOTAIR were significantly higher than serum samples from the healthy group, concluding that it can be used as a biomarker for GBM prognosis [193].